We are live on ! Find out more
INBS icon

Intelligent Bio Solutions

9 hedge funds and large institutions have $202K invested in Intelligent Bio Solutions in 2026 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

13% more funds holding

Funds holding: 8 → 9 (+1)

4.01% less ownership

Funds ownership: 7.58% → 3.58% (-4%)

46% less capital inflows, than outflows

Capital inflows: $187K | Capital outflows: $345K

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

INBS Hedge Fund Activity: Q3 2026 in Review

9 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q3 2026, worth a combined $202K — down 51% from $416K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new INBS positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.

The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $149K. The largest seller was Armistice Capital, exiting entirely with an estimated $325K sold.

  • 9 institutional investors held Intelligent Bio Solutions (INBS) as of Q3 2026, up from 8 in Q2 2026.
  • Funds reported $202K of Intelligent Bio Solutions stock for Q3 2026, down 51% quarter-over-quarter.
  • 3 funds opened new Intelligent Bio Solutions positions in Q3 2026 and 2 closed out, a net change of +1 holder.
  • The largest Intelligent Bio Solutions buyer in Q3 2026 was Alyeska Investment Group, an estimated $149K added.
  • The largest Intelligent Bio Solutions seller in Q3 2026 was Armistice Capital, an estimated $325K sold.

Based on aggregated 13F filings for Q3 2026.